SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is generating significant buzz after announcing a strategic partnership with crypto.com/us to enter the burgeoning prediction markets in the USA, alongside its plans for sports betting expansion. The active community discussion centers on the stock's exceptionally low float and recent profitability, fueling speculation of a massive short squeeze and drawing comparisons to other high-momentum market plays.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to the recent conclusion of the White House's review and approval of NOAA's revised deep seabed mining regulations, which now allow for consolidated exploration and recovery permit applications. This regulatory clarity is viewed by the community as a significant de-risking event and major catalyst, fueling anticipation for double-digit stock prices and positioning TMC as a key player in the US critical mineral independence strategy.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending due to heightened geopolitical focus on Greenland's critical mineral resources, driven by ongoing high-level discussions involving the US, Denmark, and Greenland. The community is actively speculating on potential US government involvement and a significant short squeeze, further fueled by the company's recent high-grade rare earth element drill results from its Tanbreez project.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to robust price action and high trading volume, igniting community speculation about an impending major catalyst, despite recent silence from the company. Investors are actively discussing the company's patented Optical Interposer technology as a crucial solution for power-efficient, high-speed data transfer in AI and hyperscale data centers. This surge is further fueled by market theories of institutional accumulation and indirect connections to major industry developments, with many anticipating significant partnership or order news.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing notable selling pressure, sparking community debate over its underperformance compared to tech peers and immediate downside potential influenced by options dynamics. Amidst this, conversations are actively centered on the financial implications of its substantial AI infrastructure investments, including data center energy costs, and the competitive landscape surrounding its OpenAI partnership, leading many to consider current levels a strategic buying opportunity.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a central topic of conversation, driven by positive Phase 2 data for its obesity drug VK2735 and recent remarks from a peer CEO about substantial M&A in the weight-loss market. The community is intensely focused on the potential for a major partnership or acquisition, debating VK2735's "best-in-class" attributes and its oral formulation's path to Phase 3 amid strong competition.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to heightened interest following a visit from the Secretary of War, who highlighted the company's importance to national security and implied future substantial contracts. This news, coupled with recent defense wins and progress on its Neutron rocket, is driving strong bullish sentiment among investors who envision RKLB as a key player in the burgeoning space and defense sector, even as some express caution regarding its current valuation.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is a hot topic as it unveils a partnership with NVIDIA to integrate advanced AI into its eVTOL aircraft and presents updates at a key industry conference. Enthusiastic investors are closely monitoring the stock's battle to break the $9 threshold, fueled by speculation of a short squeeze and optimistic outlooks on its progress towards air taxi trials and defense applications.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is garnering significant attention as a crucial player in the booming AI data center market, with its advanced GaN and SiC power solutions directly supporting high-efficiency architectures, including Nvidia's. The community is actively discussing the company's upcoming presentation at a major industry conference, speculating on potential contract announcements and the impact of substantial short interest. This creates a strong buzz around the stock's growth prospects and potential for a significant market move.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is actively discussed amid increasing geopolitical tensions and a strong emphasis on securing domestic critical mineral supply chains, given antimony's vital role in defense and technology. The community is anticipating potential government investments and the operational status of expanded smelter capacity, fueling expectations for significant upside due to its unique position in the North American market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IFRX Part 2 Hidden Gems according to Guggenheim (don’t shooot messanger):

“….where AMGN’s avacopan could limited
therapeutic window. IFRX has recently announced positive topline results from the Phase IIa 4-week
basket study: (1) In HS, Izicopan demonstrated rapid &amp; compelling efficacy that are aligned with
successful biologic comparators, with clear safety and a dose-dependent profile; (2) In CSU, while
the efficacy signal is stronger in HS,‘904 drives reduction in UAS7 within a range indicative of
clinical activity. Given there is no other development in the oral C5aR space, IFRX could inaugurate
a new MoA across this multibillion dollar indication market.
Initiation of a Phase II
program for Izicopan….

Also mentioned as hidden gems:
$RAPT $PHAT $SION $FBRX

Green_Dream

FlowerInTheCellar

CIELO1

Stph

Charlene Richmond

avalon E

StartSlow

$IFRX Guggenheim Just Out…..

2026 Preview of Immunological Hidden Gems Investors Probably Aren’t Folllowing….

“We believe IFRX&#39;s oral C5aR inhibitor, Izicopan (prev. INF-904), could be significant source of
value for the company. Izicopan has the potential to be a better version of $AMGN  Tavneos
(avacopan) and IFRX could adopt a fast follower approach and develop it across a number of autoimmune indications where AMGN’s avacopan could not be developed due to a limited
therapeutic window…..DATA……”

…continued. 

More to follow….

1 of 5 names listed under “hidden gems”
Also:
$ACET $ALMS $CABA

StockTwits for iOS

InflaRx N.V.

AMGEN Inc.

Adicet Bio Inc

Alumis Inc.

Cabaletta Bio Inc

RAPT Therapeutics Inc

Phathom Pharmaceuticals Inc

Sionna Therapeutics Inc

Forte Biosciences Inc

 Part 2 Hidden Gems according to Guggenheim (don’t shooot messanger):

“….where AMGN’s avacopan could limited
therapeutic window. IFRX has recently announced positive topline results from the Phase IIa 4-week
basket study: (1) In HS, Izicopan demonstrated rapid & compelling efficacy that are aligned with
successful biologic comparators, with clear safety and a dose-dependent profile; (2) In CSU, while
the efficacy signal is stronger in HS,‘904 drives reduction in UAS7 within a range indicative of
clinical activity. Given there is no other development in the oral C5aR space, IFRX could inaugurate
a new MoA across this multibillion dollar indication market.
Initiation of a Phase II
program for Izicopan….

Also mentioned as hidden gems:


Biogen Inc

Pfizer Inc

SPDR S&P Biotech ETF

Abbvie Inc

Roche Holdings AG ADR

MoonLake Immunotherapeutics

@dogDazeSummer please don’t take this personally but Guggenheim has literally zero credibility. Let’s do a recap, IFRX attended their conference in Nov ‘24, then they acted as the bookrunner of their offering in February and we all know what happened to the stock. Then they upped their target price from 7 to 10 in March and another positive note in May, after the P3 fiasco. And they went to 22 in November. Come in, let’s be serious here.

Robert Artur

@createrrit 

No offense at all taken - sharing bc most ppl on ST don’t get access to sell side research. 

Always be aware:  “Caution when feeding the seagulls” - but also $IFRX is the smallest market cap in entire 80 page report on “gem list” —some  $1B+

I doubt Guggenheim is really “making bank” off our $30M Feb offering that didn’t have an over allotment. 

Yes, they were lead underwriter - but this report is KOL based &amp; obv rewards entities who bank w them. 

Nobody is crushing it on Inflarx - not Mgt base salaries, not shareholders, not analysts, not brokerage firms, nor patients…Yet. 

Otherwise - why wld it be “a hidden gem” by definition? 

Let’s hope —-let’s pray —that Gugg and their expansive team of KOLs (who most firms wouldn’t spend $  to put on payroll) make $50M- 500M in underwriting fees.  God bless !!

If anyone deserves underwriting fees, both Cantor (via Seedhouse).  aka $RJF and Gugg are winners imo. 

Watch for some $JPM mid Jan +/-, DYOD

 please don’t take this personally but Guggenheim has literally zero credibility. Let’s do a recap, IFRX attended their conference in Nov ‘24, then they acted as the bookrunner of their offering in February and we all know what happened to the stock. Then they upped their target price from 7 to 10 in March and another positive note in May, after the P3 fiasco. And they went to 22 in November. Come in, let’s be serious here.